Elixinol Wellness (ASX:EXL) Long-Term Debt: A$0.10 Mil (As of Dec. 2025)


What is Elixinol Wellness Long-Term Debt?

Elixinol Wellness ASX:EXL Long-Term Debt is A$0.10 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Elixinol Wellness's Long-Term Debt for the quarter that ended in Dec. 2025 was A$0.10 Mil.

Elixinol Wellness's quarterly Long-Term Debt declined from Dec. 2024 (A$0.54 Mil) to Jun. 2025 (A$0.43 Mil) and declined from Jun. 2025 (A$0.43 Mil) to Dec. 2025 (A$0.10 Mil).

Elixinol Wellness's annual Long-Term Debt increased from Dec. 2023 (A$0.18 Mil) to Dec. 2024 (A$0.54 Mil) but then declined from Dec. 2024 (A$0.54 Mil) to Dec. 2025 (A$0.10 Mil).

Elixinol Wellness  (ASX:EXL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Elixinol Wellness Long-Term Debt Related Terms

Elixinol Wellness Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness Long-Term Debt Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 0.25 0.25 0.18 0.54 0.10

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.16 0.54 0.43 0.10
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$0.10 Mil mean?
Elixinol Wellness (ASX:EXL) has a Long-Term Debt of A$0.10 Mil as of Dec. 2025.
Is Elixinol Wellness' Long-Term Debt too high?
Elixinol Wellness' current Long-Term Debt is A$0.10 Mil.
How does Elixinol Wellness' Long-Term Debt compare to ZTS and UTHR?
Elixinol Wellness' Long-Term Debt of A$0.10 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Elixinol Wellness's current Long-Term Debt is A$0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ASX:EXL) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 67.5% below its estimated fair value. The current Long-Term Debt is A$0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Elixinol Wellness (ASX:EXL), the current Long-Term Debt is A$0.10 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges ELLXF:USAE8M:Germany
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.